Malaria Vaccine Search To Be Accelerated By Expanding Human Challenge Tests

In a move that should expedite the clinical assessment of malaria vaccine candidates, the PATH Malaria Vaccine Initiative (MVI) and Seattle Biomedical Research Institute (SBRI) has announced a new collaboration to establish a center devoted to testing the safety and efficacy of malaria vaccine candidates in humans.

More: continued here

Filed under: Tropical on March 14th, 2008